201
|
Yeol SG, Won YS, Kim YI, Lee JW, Choi YJ, Park DC. Decreased Bcl-6 and increased Blimp-1 in the peritoneal cavity of patients with endometriosis. CLIN EXP OBSTET GYN 2015; 42:156-160. [PMID: 26054109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
PURPOSE OF INVESTIGATION The authors investigated the expression patterns of interleukin (IL)-lβ and tumor necrosis factor (TNF)-α, cytokines associated with peritoneal inflammatory reactions, and of B cell leukemia lymphoma (Bcl)-6 and B lymphocyte inducer of maturation program (Blimp)-1, transcriptional factors associated with immunoglobulin (Ig) production; the concentrations of Igs, and their correlation, in patients with and without endometriosis. MATERIALS AND METHODS The authors analyzed the peritoneal fluid of 98 patients, 46 with endometriosis, and 52 with benign tumors. RESULTS IL-1 and TNF-α mRNAs and IgG and IgA concentrations were higher in the endometriosis group, but the differences were not statistically significant. However, Bcl-6 mRNA level was significantly lower and Blimp-1 mRNA level was significantly higher in the endometriosis group with significant correlations among transcriptional factors, Igs, and cytokines (p < 0.05). CONCLUSION Peritoneal immune responses in patients with endometriosis may be due to increased IgG and IgA concentrations, as well as to changes in expression of proinflammatory cytokines and transcriptional factors.
Collapse
|
202
|
Kim JI, Lee SS, Choi JK, Lee JW, Lee JY. A Case of Chemical Meningitis Induced by Intrathecal Bupivacaine Injection. J Neurocrit Care 2014. [DOI: 10.18700/jnc.2014.7.2.122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
203
|
Kang HG, Jeong DH, Yang JJ, Lee BK, Kong JK, Lee JW, Kim IH. Serial transrectal ultrasonography for monitoring the reproductive activity of the Asiatic black bear (Ursus thibetanus ussuricus). Reprod Domest Anim 2014; 50:149-58. [PMID: 25522189 DOI: 10.1111/rda.12470] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2014] [Accepted: 11/25/2014] [Indexed: 12/01/2022]
Abstract
This study evaluated the structural changes in the reproductive tract of Asiatic black bears using serial transrectal ultrasonography. In addition, the ultrasonographic observations were compared with the results of vaginal cytology and hormonal analyses. The collection of blood for hormonal analysis, vaginal cytology and transrectal ultrasonography was performed in two bears (Bears 1 and 2) from June 2011 to August 2013 without mating and in a third bear (Bear 3) from April to December 2012, allowing natural mating. Serial ultrasonographic observations showed cyclic changes in ovarian structures (e.g. emergence of small follicles, growth and ovulation of dominant follicles and corpus luteum (CL) formation) during the reproductive cycles of the three bears. The diameter of the uterine horns remained similar throughout the reproductive cycle in Bears 1 and 2, and it remained similar from April until October, but an enlargement containing foetuses was observed in Bear 3 in December. The ultrasonographic observations were consistent with the data obtained through vaginal cytology and progesterone analysis during the reproductive cycle. An average of 4.0 (±0.4) dominant follicles was observed during the oestrous stage (May-August), during which the superficial cells accounted for >90% of the total vaginal cells. In addition, the detection of an average of 2.6 (±0.2) CL was associated with increased plasma progesterone concentrations (3.0 ± 0.4 ng/ml) between June and December (near hibernation). In conclusion, serial transrectal ultrasonography demonstrated yearly oestrous (ovulation) cycles via follicular dynamics and CL formation on ovaries, accordingly with vaginal cytology and hormonal level in the Asiatic black bear.
Collapse
Affiliation(s)
- H G Kang
- College of Veterinary Medicine, Chungbuk National University, Cheongju, Korea
| | | | | | | | | | | | | |
Collapse
|
204
|
Kim HH, Lee JW, Cha KS, Chung DH, Lee SM. Three-dimensional assessment of upper lip positional changes according to simulated maxillary anterior tooth movements by white light scanning. Korean J Orthod 2014; 44:281-93. [PMID: 25473644 PMCID: PMC4250662 DOI: 10.4041/kjod.2014.44.6.281] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2014] [Revised: 05/26/2014] [Accepted: 06/13/2014] [Indexed: 11/10/2022] Open
Abstract
Objective Esthetic improvements during orthodontic treatment are achieved by changes in positions of the lips and surrounding soft tissues. Facial soft-tissue movement has already been two-dimensionally evaluated by cephalometry. In this study, we aimed to three-dimensionally assess positional changes of the adult upper lip according to simulated maxillary anterior tooth movements by white light scanning. Methods We measured changes in three-dimensional coordinates of labial landmarks in relation to maxillary incisor movements of normal adults simulated with films of varying thickness by using a white light scanner. Results With increasing protraction, the upper lip moved forward and significantly upward. Labial movement was limited by the surrounding soft tissues. The extent of movement above the vermilion border was slightly less than half that of the teeth, showing strong correlation. Most changes were concentrated in the depression above the upper vermilion border. Labial movement toward the nose was reduced significantly. Conclusions After adequately controlling several variables and using white light scanning with high reproducibility and accuracy, the coefficient of determination showed moderate values (0.40-0.77) and significant changes could be determined. This method would be useful to predict soft-tissue positional changes according to tooth movements.
Collapse
Affiliation(s)
- Hwee-Ho Kim
- Department of Orthodontics, School of Dentistry, Dankook University, Cheonan, Korea
| | - Jin-Woo Lee
- Department of Orthodontics, School of Dentistry, Dankook University, Cheonan, Korea
| | - Kyung-Suk Cha
- Department of Orthodontics, School of Dentistry, Dankook University, Cheonan, Korea
| | - Dong-Hwa Chung
- Department of Orthodontics, School of Dentistry, Dankook University, Cheonan, Korea
| | - Sang-Min Lee
- Department of Orthodontics, School of Dentistry, Dankook University, Cheonan, Korea
| |
Collapse
|
205
|
Yang J, Lee JW, Jung BK, Chung KJ, Hwang YS. Development of internal magnetic probe for current density profile measurement in Versatile Experiment Spherical Torus. Rev Sci Instrum 2014; 85:11D809. [PMID: 25430222 DOI: 10.1063/1.4886429] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
An internal magnetic probe using Hall sensors to measure a current density profile directly with perturbation of less than 10% to the plasma current is successfully operated for the first time in Versatile Experiment Spherical Torus (VEST). An appropriate Hall sensor is chosen to produce sufficient signals for VEST magnetic field while maintaining the small size of 10 mm in outer diameter. Temperature around the Hall sensor in a typical VEST plasma is regulated by blown air of 2 bars. First measurement of 60 kA VEST ohmic discharge shows a reasonable agreement with the total plasma current measured by Rogowski coil in VEST.
Collapse
Affiliation(s)
- J Yang
- Department of Nuclear Engineering, Seoul National University, Seoul 151-744, South Korea
| | - J W Lee
- Department of Nuclear Engineering, Seoul National University, Seoul 151-744, South Korea
| | - B K Jung
- SNU Division of Graduate Education for Sustainabilization of Foundation Energy, Seoul National University, Seoul 151-744, South Korea
| | - K J Chung
- SNU Division of Graduate Education for Sustainabilization of Foundation Energy, Seoul National University, Seoul 151-744, South Korea
| | - Y S Hwang
- Department of Nuclear Engineering, Seoul National University, Seoul 151-744, South Korea
| |
Collapse
|
206
|
Oh JH, Song BW, Kim SH, Choi JA, Lee JW, Chung SW, Rhie TY. The measurement of bone mineral density of bilateral proximal humeri using DXA in patients with unilateral rotator cuff tear. Osteoporos Int 2014; 25:2639-48. [PMID: 25027108 DOI: 10.1007/s00198-014-2795-1] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/20/2013] [Accepted: 06/24/2014] [Indexed: 02/03/2023]
Abstract
UNLABELLED We propose that the measurement of the bone mineral density (BMD) of the proximal humerus be standardized using the dual energy X-ray absorptiometry (DXA) in patients supposed to undergo rotator cuff repair surgery as well as those with the fracture of the proximal humerus as the BMD of the proximal humerus is decreased in these patients. INTRODUCTION We propose that the measurement of the BMD of the proximal humerus be standardized using the DXA in patients who are supposed to undergo rotator cuff repair surgery as well as those with the fracture of the proximal humerus. METHODS We conducted the prospective study in 213 patients with unilateral rotator cuff tear but without contralateral shoulder pain or disease. In these patients, we preoperatively measured the BMD of the bilateral proximal humeri with a repeat measurement in 20 patients. We predefined three regions of interest (ROIs) in the proximal humerus with the consideration of the rotator cuff repair surgery as well as proximal humeral fractures. RESULTS The measurement of the BMD of the proximal humerus using the DXA showed excellent reliability (intraclass correlation coefficient > .90). BMD values of all three ROIs in the affected shoulder were significantly lower than those in asymptomatic shoulder (all p < 0.05). In female patients, the BMD values of ROIs in bilateral shoulder were significantly lower than those in male patients (all p < 0.001). In multiple regressions, however, there were no significant correlations between other clinical characteristics, except for the gender, and the BMD of GT in the affected shoulder. CONCLUSIONS It is imperative that the bone quality of the proximal humerus be accurately evaluated prior to surgery in patients who are supposed to undergo rotator cuff repair using suture anchors as well as in those with proximal humeral fractures. This is because the BMD of the proximal humerus is decreased in these patients.
Collapse
Affiliation(s)
- J H Oh
- Department of Orthopaedic Surgery, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea
| | | | | | | | | | | | | |
Collapse
|
207
|
Abstract
An intracranial tumor is a rare cause of secondary parkinsonism. Our patient presented to our clinic for recently-developed asymmetric parkinsonism without pyramidal signs. However, a meningioma located in the sphenoidal ridge was identified upon imaging studies. This case suggests that additional causes should be considered when approaching patients with parkinsonism and that imaging studies can provide useful information to make accurate diagnoses.
Collapse
Affiliation(s)
- Ji-In Kim
- Department of Neurology, Yonsei University Wonju College of Medicine, Wonju, Korea
| | - Jin Kyo Choi
- Department of Neurology, Yonsei University Wonju College of Medicine, Wonju, Korea
| | - Jin-Woo Lee
- Department of Neurology, Yonsei University Wonju College of Medicine, Wonju, Korea
| | - Jin Yong Hong
- Department of Neurology, Yonsei University Wonju College of Medicine, Wonju, Korea
| |
Collapse
|
208
|
Carleton BC, Ross CJ, Pussegoda K, Bhavsar AP, Visscher H, Lee JW, Brooks B, Rassekh SR, Dubé MPP, Hayden MR. Genetic Markers of Cisplatin-Induced Hearing Loss in Children. Clin Pharmacol Ther 2014; 96:296-8. [DOI: 10.1038/clpt.2014.92] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
209
|
An HS, Kim HY, Kim JB, Chang DS, Park KD, Lee JW, Myeong JI, An CM. Genetic characterization of hatchery populations of Korean spotted sea bass (Lateolabrax maculatus) using multiplex polymerase chain reaction assays. Genet Mol Res 2014; 13:6701-15. [PMID: 25177950 DOI: 10.4238/2014.august.28.14] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
The spotted sea bass, Lateolabrax maculatus, is an important commercial and recreational fishery resource in Korea. Aquacultural production of this species has increased because of recent resource declines, growing consumption, and ongoing government-operated stock release programs. Therefore, the genetic characterization of hatchery populations is necessary to maintain the genetic diversity of this species and to develop more effective aquaculture practices. In this study, the genetic diversity and structure of three cultured populations in Korea were assessed using multiplex assays with 12 highly polymorphic microsatellite loci; 144 alleles were identified. The number of alleles per locus ranged from 6 to 28, with an average of 13.1. The mean observed and expected heterozygosities were 0.724 and 0.753, respectively. Low levels of inbreeding were detected according to the inbreeding coefficient (mean FIS = 0.003-0.073). All hatchery populations were significantly differentiated from each other (overall fixation index (FST) = 0.027, P < 0.01), and no population formed a separate cluster. Pairwise multilocus FST tests, estimates of genetic distance, mantel test, and principal component analyses did not show a consistent relationship between geographic and genetic distances. These results could reflect the exchange of breeds and eggs between hatcheries and/or genetic drift due to intensive breeding practices. For optimal resource management, the genetic variation of hatchery stocks should be monitored and inbreeding controlled within the spotted sea bass stocks that are being released every year. This genetic information will be useful for the management of both L. maculatus fisheries and the aquaculture industry.
Collapse
Affiliation(s)
- H S An
- Biotechnology Research Division, National Fisheries Research and Development Institute, Busan, Korea
| | - H Y Kim
- Fisheries Resources and Environment Division, Southwest Sea Fisheries Research Institute, National Fisheries Research and Development Institute, Yeosu, Korea
| | - J B Kim
- Fisheries Resources and Environment Division, Southwest Sea Fisheries Research Institute, National Fisheries Research and Development Institute, Yeosu, Korea
| | - D S Chang
- Fisheries Resources and Environment Division, Southwest Sea Fisheries Research Institute, National Fisheries Research and Development Institute, Yeosu, Korea
| | - K D Park
- Fishery Resource Research Institute, Gyongsangnamdo, Korea
| | - J W Lee
- Aquaculture Management Division, National Fisheries Research and Development Institute, Busan, Korea
| | - J I Myeong
- Aquaculture Management Division, National Fisheries Research and Development Institute, Busan, Korea
| | - C M An
- Biotechnology Research Division, National Fisheries Research and Development Institute, Busan, Korea
| |
Collapse
|
210
|
Lee KM, Chung DH, Lee JW, Lee SM. Cervical vertebrae maturation, dentoalveolar, head postural and respiratory parameters in predicting the stable outcome of face-mask treatment. Eur J Orthod 2014; 37:251-6. [PMID: 25164062 DOI: 10.1093/ejo/cju035] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
BACKGROUND/OBJECTIVES To select predictors related to cervical vertebrae maturation (CVM), dentoalveolar adaptation, head posture, and respiration on outcome of face-mask treatment. MATERIALS/METHODS Forty-six patients (24 boys and 22 girls) with skeletal Class III pattern whose CVM stages ranged from I to IV at pretreatment were selected. The observation period was 2.87 ± 1.77 years from the end of treatment. Negative overjet and overbite was regarded as unstable. CVM, 10 skeletal variables, 6 dental adaptation variables, 4 alveolar housing variables, an airway variable, and 2 head posture variables were chosen for discriminant analysis of initial characteristics between stable and unstable groups. RESULTS Measurements exhibiting strong correlations were distance from lower incisor to Nasion, B point (NB), Frankfort horizontal plane to Mandibular incisor Angle (FMIA), incisor overbite, body to anterior cranial base. LIMITATIONS We missed muscle-related variables, which cannot be identified in a cephalogram. CONCLUSIONS/IMPLICATIONS Presence of non-skeletal cephalometric factors more closely associated with stability of face-mask treatment rather than skeletal cephalometric factors at the initial stage are confirmed.
Collapse
Affiliation(s)
- Kwang-Min Lee
- Department of Orthodontics and the Graduate School of Dentistry, Dankook University, Cheonan, Korea
| | - Dong-Hwa Chung
- Department of Orthodontics and the Graduate School of Dentistry, Dankook University, Cheonan, Korea
| | - Jin-Woo Lee
- Department of Orthodontics and the Graduate School of Dentistry, Dankook University, Cheonan, Korea
| | - Sang-Min Lee
- Department of Orthodontics and the Graduate School of Dentistry, Dankook University, Cheonan, Korea
| |
Collapse
|
211
|
Choi OK, Song JS, Cha DK, Lee JW. Biodiesel production from wet municipal sludge: evaluation of in situ transesterification using xylene as a cosolvent. Bioresour Technol 2014; 166:51-56. [PMID: 24905042 DOI: 10.1016/j.biortech.2014.05.001] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/26/2014] [Revised: 04/26/2014] [Accepted: 05/02/2014] [Indexed: 06/03/2023]
Abstract
This study proposes a method to produce biodiesel from wet wastewater sludge. Xylene was used as an alternative cosolvent to hexane for transesterification in order to enhance the biodiesel yield from wet wastewater sludge. The water present in the sludge could be separated during transesterification by employing xylene, which has a higher boiling point than water. Xylene enhanced the biodiesel yield up to 8.12%, which was 2.5 times higher than hexane. It was comparable to the maximum biodiesel yield of 9.68% obtained from dried sludge. Xylene could reduce either the reaction time or methanol consumption, when compared to hexane for a similar yield. The fatty acid methyl esters (FAMEs) content of the biodiesel increased approximately two fold by changing the cosolvent from hexane to xylene. The transesterification method using xylene as a cosolvent can be applied effectively and economically for biodiesel recovery from wet wastewater sludge without drying process.
Collapse
Affiliation(s)
- O K Choi
- Program in Environmental Technology and Policy, Korea University, Sejong 339-700, Republic of Korea
| | - J S Song
- Department of Environmental Engineering, College of Science and Technology, Korea University, Sejong 339-700, Republic of Korea
| | - D K Cha
- Department of Civil and Environmental Engineering, University of Delaware, Newark, DE, USA
| | - J W Lee
- Program in Environmental Technology and Policy, Korea University, Sejong 339-700, Republic of Korea; Department of Environmental Engineering, College of Science and Technology, Korea University, Sejong 339-700, Republic of Korea.
| |
Collapse
|
212
|
Chung CH, Lee JW, Slebos RJ, Howard JD, Perez J, Kang H, Fertig EJ, Considine M, Gilbert J, Murphy BA, Nallur S, Paranjape T, Jordan RC, Garcia J, Burtness B, Forastiere AA, Weidhaas JB. A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. Ann Oncol 2014; 25:2230-2236. [PMID: 25081901 DOI: 10.1093/annonc/mdu367] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
BACKGROUND A germline mutation in the 3'-untranslated region of KRAS (rs61764370, KRAS-variant: TG/GG) has previously been associated with altered patient outcome and drug resistance/sensitivity in various cancers. We examined the prognostic and predictive significance of this variant in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). PATIENTS AND METHODS We conducted a retrospective study of 103 HNSCCs collected from three completed clinical trials. KRAS-variant genotyping was conducted for these samples and 8 HNSCC cell lines. p16 expression was determined in a subset of 26 oropharynx tumors by immunohistochemistry. Microarray analysis was also utilized to elucidate differentially expressed genes between KRAS-variant and non-variant tumors. Drug sensitivity in cell lines was evaluated to confirm clinical findings. RESULTS KRAS-variant status was determined in 95/103 (92%) of the HNSCC tumor samples and the allelic frequency of TG/GG was 32% (30/95). Three of the HNSCC cell lines (3/8) studied had the KRAS-variant. No association between KRAS-variant status and p16 expression was observed in the oropharynx subset (Fisher's exact test, P = 1.0). With respect to patient outcome, patients with the KRAS-variant had poor progression-free survival when treated with cisplatin (log-rank P = 0.002). Conversely, KRAS-variant patients appeared to experience some improvement in disease control when cetuximab was added to their platinum-based regimen (log-rank P = 0.04). CONCLUSIONS The TG/GG rs61764370 KRAS-variant is a potential predictive biomarker for poor platinum response in R/M HNSCC patients. CLINICAL TRIAL REGISTRATION NUMBERS NCT00503997, NCT00425750, NCT00003809.
Collapse
Affiliation(s)
- C H Chung
- Department of Oncology; Department of Otolaryngology-Head and Neck Surgery, Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore.
| | - J W Lee
- Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston
| | | | | | | | | | | | | | - J Gilbert
- Division of Hematology/Oncology, Department of Medicine, Vanderbilt University, Nashville
| | - B A Murphy
- Division of Hematology/Oncology, Department of Medicine, Vanderbilt University, Nashville
| | - S Nallur
- Department of Therapeutic Radiology
| | | | - R C Jordan
- Department of Pathology, University of California, San Francisco
| | | | - B Burtness
- Section of Medical Oncology, Department of Internal Medicine, Yale University School of Medicine, New Haven
| | | | - J B Weidhaas
- Department of Therapeutic Radiology; Department of Radiation Oncology, University of California, Los Angeles
| |
Collapse
|
213
|
Lee SH, Joo YK, Lee JW, Ha YJ, Yeo JM, Kim WY. Dietary Conjugated Linoleic Acid (CLA) increases milk yield without losing body weight in lactating sows. J Anim Sci Technol 2014; 56:11. [PMID: 26290700 PMCID: PMC4540305 DOI: 10.1186/2055-0391-56-11] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 05/15/2014] [Accepted: 07/24/2014] [Indexed: 11/10/2022]
Abstract
This study was conducted to evaluate the effects of dietary conjugated linoleic acid (CLA) on the performance of lactating sows and piglets as well as the immunity of piglets suckling from sows fed CLA. Eighteen multiparous Duroc sows with an average body weight (BW) of 232.0 ± 6.38 kg were randomly selected and assigned to two dietary treatments (n = 9 for each treatment), control (no CLA addition) and 1% CLA supplementation. For the control diet, CLA was replaced with soybean oil. Experimental diets were fed to sows during a 28-day lactation period. Litter size for each sow was standardized to nine piglets by cross-fostering within 24 hours after birth. Sow milk and blood samples were taken from sows and piglets after 21 and 27 days of lactation, respectively. Loss of BW was significantly (p < 0.05) higher in sows fed control diet compared to sows fed CLA diet. Piglet weights at weaning and weight gain during suckling were significantly (p < 0.05) higher in sows fed CLA compared to sows fed control diet. Serum non-esterified fatty acid (NEFA) and urea nitrogen concentrations were significantly (p < 0.05) lower in sows fed CLA than in sows fed soybean oil. IgG concentrations of the groups supplemented with CLA increased by 49% in sow serum (p < 0.0001), 23% in milk (p < 0.05), and 35% in piglet serum (p < 0.05) compared with the control group. Sows fed CLA showed an increase of 10% in milk yield compared with sows fed soybean oil (p < 0.05), even though there was no difference in daily feed intake between the treatments. Milk fat content was significantly (p < 0.05) lower in sows fed CLA than in sows fed soybean oil. Solid-not-fat yield was significantly (p < 0.05) higher in sows supplemented with CLA than in sows fed control diet and also protein-to-fat ratio in milk was significantly (p < 0.05) higher in sows fed CLA compared with the control group. The results show that CLA supplementation to sows increased milk yield without losing BW during lactation, whereas soybean oil supplementation resulted in severe BW loss.
Collapse
Affiliation(s)
- Sung-Hoon Lee
- Livestock Experiment Station, Gyeongsangnamdo Livestock Promotion Research Institute, 251 Cheonghyun-ro, Sinan-myeon, Sancheong, 666-962 Republic of Korea
| | - Young-Kuk Joo
- Livestock Experiment Station, Gyeongsangnamdo Livestock Promotion Research Institute, 251 Cheonghyun-ro, Sinan-myeon, Sancheong, 666-962 Republic of Korea
| | - Jin-Woo Lee
- Livestock Experiment Station, Gyeongsangnamdo Livestock Promotion Research Institute, 251 Cheonghyun-ro, Sinan-myeon, Sancheong, 666-962 Republic of Korea
| | - Young-Joo Ha
- Livestock Experiment Station, Gyeongsangnamdo Livestock Promotion Research Institute, 251 Cheonghyun-ro, Sinan-myeon, Sancheong, 666-962 Republic of Korea
| | - Joon-Mo Yeo
- Department of Beef & Dairy Science, Korea National College of Agriculture and Fisheries, 212 Hyohaeng-ro, Bongdam-eup, Hwaseong, 445-760 Republic of Korea
| | - Wan-Young Kim
- Department of Beef & Dairy Science, Korea National College of Agriculture and Fisheries, 212 Hyohaeng-ro, Bongdam-eup, Hwaseong, 445-760 Republic of Korea
| |
Collapse
|
214
|
Gao W, Kim HJ, Chung CH, Lee JW. Enhanced Production of carboxymethylcellulase by a marine bacterium, Bacillus velezensis A-68, by using rice hulls in pilot-scale bioreactor under optimized conditions for dissolved oxygen. J Microbiol 2014; 52:755-61. [DOI: 10.1007/s12275-014-4156-3] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2014] [Revised: 05/07/2014] [Accepted: 06/02/2014] [Indexed: 11/29/2022]
|
215
|
Park HJ, Park M, Han M, Nam BH, Koh KN, Im HJ, Lee JW, Chung NG, Cho B, Kim HK, Yoo KH, Koo HH, Kang HJ, Shin HY, Ahn HS, Lim YT, Kook H, Lyu CJ, Hah JO, Park JE, Lim YJ, Seo JJ. Efficacy and safety of micafungin for the prophylaxis of invasive fungal infection during neutropenia in children and adolescents undergoing allogeneic hematopoietic SCT. Bone Marrow Transplant 2014; 49:1212-6. [PMID: 25000455 DOI: 10.1038/bmt.2014.136] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2013] [Revised: 05/12/2014] [Accepted: 05/18/2014] [Indexed: 11/09/2022]
Abstract
The objective of this study was to evaluate the efficacy and safety of micafungin for the prevention of invasive fungal infection (IFI) during the neutropenic phase of allogeneic hematopoietic SCT (allo-HSCT) in children and adolescents. This was a prospective, multicenter, open-label, single-arm study. Micafungin was administered i.v. at a dose of 1 mg/kg/day (max 50 mg) from the beginning of conditioning until neutrophil engraftment. Treatment success was defined as the absence of proven, probable, possible or suspected IFI through to 4 weeks after therapy. From April 2010 to December 2011, 155 patients were enrolled from 11 institutions in Korea, and 147 patients were analyzed. Of the 147 patients, 121 (82.3%) completed the protocol without premature interruption. Of the 132 patients in whom micafungin efficacy could be evaluated, treatment success was achieved in 119 patients (90.2%). There was no proven fungal infection in any patient. The number of patients with probable, possible and suspected IFI was two, two and nine, respectively. Thirty-five patients (23.8%) experienced 109 adverse events (AEs) possibly related to micafungin. No patients experienced grade IV AEs. Two patients (1.4%) discontinued micafungin administration due to adverse effects. None of the deaths were related to the study drug.
Collapse
Affiliation(s)
- H J Park
- Center for Pediatric Oncology, National Cancer Center, Goyang-si, Republic of Korea
| | - M Park
- Department of Pediatrics, Chungbuk National University College of Medicine, Cheongju, Republic of Korea
| | - M Han
- Clinical Research Center, National Cancer Center, Goyang-si, Republic of Korea
| | - B H Nam
- Clinical Research Center, National Cancer Center, Goyang-si, Republic of Korea
| | - K N Koh
- Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - H J Im
- Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea
| | - J W Lee
- Department of Pediatrics, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea
| | - N-G Chung
- Department of Pediatrics, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea
| | - B Cho
- Department of Pediatrics, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea
| | - H-K Kim
- Department of Pediatrics, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea
| | - K H Yoo
- Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
| | - H H Koo
- Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
| | - H J Kang
- Department of Pediatrics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - H Y Shin
- Department of Pediatrics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - H S Ahn
- Department of Pediatrics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - Y T Lim
- Department of Pediatrics, Pusan National University College of Medicine, Busan, Republic of Korea
| | - H Kook
- Department of Pediatrics, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea
| | - C J Lyu
- Department of Pediatrics, Yonsei University, College of Medicine, Seoul, Republic of Korea
| | - J O Hah
- Department of Pediatrics, Yeungnam University College of Medicine, Daegu, Republic of Korea
| | - J E Park
- Department of Pediatrics, Ajou University School of Medicine, Suwon, Republic of Korea
| | - Y J Lim
- Department of Pediatrics, Chungnam National University School of Medicine, Daejon, Republic of Korea
| | - J J Seo
- Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea
| |
Collapse
|
216
|
Lee JW, Aminkeng F, Bhavsar AP, Shaw K, Carleton BC, Hayden MR, Ross CJD. The emerging era of pharmacogenomics: current successes, future potential, and challenges. Clin Genet 2014; 86:21-8. [PMID: 24684508 PMCID: PMC4233969 DOI: 10.1111/cge.12392] [Citation(s) in RCA: 56] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2014] [Revised: 03/24/2014] [Accepted: 03/27/2014] [Indexed: 12/20/2022]
Abstract
The vast range of genetic diversity contributes to a wonderful array of human traits and characteristics. Unfortunately, a consequence of this genetic diversity is large variability in drug response between people, meaning that no single medication is safe and effective in everyone. The debilitating and sometimes deadly consequences of adverse drug reactions (ADRs) are a major and unmet problem of modern medicine. Pharmacogenomics can uncover associations between genetic variation and drug safety and has the potential to predict ADRs in individual patients. Here we review pharmacogenomic successes leading to changes in clinical practice, as well as clinical areas probably to be impacted by pharmacogenomics in the near future. We also discuss some of the challenges, and potential solutions, that remain for the implementation of pharmacogenomic testing into clinical practice for the significant improvement of drug safety.
Collapse
Affiliation(s)
- J W Lee
- Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, The University of British Columbia, Vancouver, BC, Canada; Child & Family Research Institute, Vancouver, BC, Canada
| | | | | | | | | | | | | |
Collapse
|
217
|
Yi YB, Lee JW, Chung CH. Sustainable Approach to Catalytic Conversion of Starch-based Biomaterials into Hydroxymethylfurfural Using Ionic Liquids. CURR ORG CHEM 2014. [DOI: 10.2174/1385272819999140526163023] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
218
|
Lai CL, Ahn SH, Lee KS, Um SH, Cho M, Yoon SK, Lee JW, Park NH, Kweon YO, Sohn JH, Lee J, Kim JA, Han KH, Yuen MF. Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B. Gut 2014; 63:996-1004. [PMID: 23979965 DOI: 10.1136/gutjnl-2013-305138] [Citation(s) in RCA: 58] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
BACKGROUND Besifovir (LB80380) is an acyclic nucleotide phosphonate effective in hepatitis B virus (HBV) DNA suppression for both treatment-naive and lamivudine-resistant chronic hepatitis B (CHB) patients in preliminary studies. DESIGN We aimed to compare the safety and antiviral activity of two doses of besifovir (90 mg and 150 mg daily) with entecavir 0.5 mg daily in CHB patients. 114 patients were randomised to receive besifovir 90 mg daily (n=36), besifovir 150 mg daily (n=39) or entecavir 0.5 mg daily (n=39). HBV DNA and liver biochemistry, including serum L-carnitine levels, were monitored. RESULTS At week 48, in the intention-to-treat population, the proportion of patients achieving undetectable HBV DNA (<20 IU/mL) were 63.6%, 62.9% and 58.3%, respectively (p>0.05). The serum mean log10 HBV DNA changes from baseline for the HBeAg-positive patients were -5.84, -5.91 and -6.18, respectively; and for the HBeAg-negative patients were -4.65, -4.55 and -4.67, respectively (p>0.05). There were no differences in the proportions of patients achieving normalisation of alanine aminotransferase (91.7%, 76.9%, 89.7%, respectively) and HBeAg seroconversion (11.11%, 15%, 9.52%, respectively) among all three groups. None of the patients had resistant mutations or increase in serum creatinine of >0.5 mg/dL from baseline. 64 (94.1%) patients on besifovir had lowering of serum L-carnitine (not tested in entecavir patients). L-carnitine levels returned to normal with carnitine supplement. CONCLUSIONS At 48 weeks, 90 mg and 150 mg daily of besifovir were non-inferior to entecavir 0.5 mg daily in treatment-naive CHB patients. The only significant side effect of besifovir was L-carnitine depletion, requiring carnitine supplementation.
Collapse
Affiliation(s)
- Ching-Lung Lai
- Department of Medicine, University of Hong Kong, Hong Kong, Hong Kong
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
219
|
Lee JI, Kim JK, Chang HY, Lee JW, Kim JM, Chung HJ, Kim YS, Lee KS. Impact of postoperative hepatitis B virus reactivation in hepatocellular carcinoma patients who formerly had naturally suppressed virus. J Gastroenterol Hepatol 2014; 29:1019-27. [PMID: 24325315 DOI: 10.1111/jgh.12472] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 11/27/2013] [Indexed: 12/13/2022]
Abstract
BACKGROUND AND AIM Hepatitis B virus (HBV) replication detected before the resection of hepatocellular carcinoma (HCC) is to be controlled by antiviral agents. However, management strategy for patients with preoperatively undetectable HBV DNA without antiviral therapy is not clearly delineated. This study investigated viral reactivation after the liver resection in non-replicating HBV DNA-related HCC patients and its impact on the surgical outcome. METHODS From 198 patients that underwent liver resection due to HBV-related HCC, 101 patients who had serially checked serum HBV DNA were analyzed. RESULTS From 101 patients, 33 patients had baseline undetectable HBV DNA. Eleven patients (11/33, 33.3%) had viral replication after the liver resection. The postoperative viral reactivation (HR: 2.144; 95% CI: 1.122-4.097; P = 0.021), along with the existence of satellite nodules (HR: 3.034; 95% CI: 1.1.376-6.689; P = 0.006), existence of microvascular invasion (HR: 2.479; 95% CI: 1.303-4.718; P = 0.006), and HBeAg positivity (HR: 2.059; 95% CI: 1.155-3.670; P = 0.014) predicted recurrence after the surgery. Quantification of intrahepatic total and covalently closed circular DNA (cccDNA) was done in 14 patients whose baseline serum HBV DNA was undetectable without the use of antiviral agent. Amount of intrahepatic cccDNA expressed as copies/hepatocyte in patients with postoperative viral reactivation showed significantly higher than those in patients with sustained negative serum HBV DNA (P = 0.010). CONCLUSIONS This study shows that naturally suppressed preoperative HBV without application of antiviral agent does not ensure undetectable serum HBV after the surgery, and postoperative viral reactivation might be associated with HCC recurrence.
Collapse
Affiliation(s)
- Jung Il Lee
- Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; Liver Cirrhosis Clinical Trial Center, Seoul, Republic of Korea
| | | | | | | | | | | | | | | |
Collapse
|
220
|
Jin YJ, Lee JW, Lee OH, Chung HJ, Kim YS, Lee JI, Cho SG, Jeon YS, Lee KY, Ahn SI, Shin WY. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion. J Gastroenterol Hepatol 2014; 29:1056-64. [PMID: 24372785 DOI: 10.1111/jgh.12507] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 12/09/2013] [Indexed: 02/06/2023]
Abstract
BACKGROUND/AIMS Microvascular invasion (MVI) is a well-known prognostic factor of postoperative recurrence and of overall survival (OS) in patients with hepatocellular carcinoma (HCC). We compared the treatment outcomes of transarterial chemoembolization (TACE) and surgery/radiofrequency ablation (RFA) according to the presence of MVI in patients with early or late recurrent HCC that presented as Barcelona Clinical Liver Cancer (BCLC) stage 0 or A after curative resection for HCC. METHODS A consecutive 68 patients with recurrent HCC of BCLC stage 0 or A at our institution between 1998 and 2012 were retrospectively enrolled. We compared the outcomes of patients treated by TACE or surgery/RFA. Tumor recurrence after curative resection was classified as early (≤ 12 months) or late (> 12 months) recurrence. RESULTS Median tumor size was 1.5 cm (range, 1-10 cm), and 67 (98.5%) had HCCs within the Milan criteria. Median post-retreatment follow-up duration was 27 months (range, 1-109 months). Of the 68 patients, 19 (27.9%) underwent surgery/RFA, 47 (69.1%) TACE, and 2 (2.9%) were lost to follow-up. After retreatment, TACE showed significantly higher OS and recurrence-free survival rates than surgery/RFA in MVI-positive patients (P = 0.03 and P = 0.05, respectively), but not in MVI-negative patients (P = 0.95 and P = 0.98, respectively). In particular, in early recurred MVI-positive patients, TACE had a significantly higher OS rate than surgery/RFA (P = 0.01). CONCLUSIONS TACE may be the more effective treatment option for recurrent HCC of BCLC stage 0 or A than surgery/RFA in MVI-positive patients, especially in those that recur early after curative resection.
Collapse
Affiliation(s)
- Young-Joo Jin
- Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, South Korea
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
221
|
Kim MG, Lee JW, Cha KS, Chung DH, Lee SM. Three-dimensional symmetry and parallelism of the skeletal and soft-tissue poria in patients with facial asymmetry. Korean J Orthod 2014; 44:62-8. [PMID: 24696822 PMCID: PMC3971127 DOI: 10.4041/kjod.2014.44.2.62] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2012] [Revised: 06/26/2013] [Accepted: 06/28/2013] [Indexed: 11/10/2022] Open
Abstract
Objective The purpose of this study was to examine the symmetry and parallelism of the skeletal and soft-tissue poria by three-dimensional (3D) computed tomographic (CT) imaging. Methods The locations of the bilateral skeletal and soft-tissue poria in 29 patients with facial asymmetry (asymmetric group) and 29 patients without facial asymmetry (symmetric group) were measured in 3D reconstructed models of CT images by using a 3D coordinate system. The mean intergroup differences in the anteroposterior and vertical angular deviations of the poria and their anteroposterior and vertical parallelism were statistically analyzed. Results The symmetric and asymmetric groups showed significant anteroposterior angular differences in both the skeletal and the soft-tissue poria (p = 0.007 and 0.037, respectively; Mann-Whitney U-test). No significant differences in the anteroposterior and vertical parallelism of the poria were noted (p ≤ 0.05; Wilcoxon signed-rank test). Conclusions In general, the skeletal poria are parallel to the soft-tissue poria. However, patients with facial asymmetry tend to have asymmetric poria.
Collapse
Affiliation(s)
- Min-Gun Kim
- Department of Orthodontics, School of Dentistry, Dankook University, Cheonan, Korea
| | - Jin-Woo Lee
- Department of Orthodontics, School of Dentistry, Dankook University, Cheonan, Korea
| | - Kyung-Suk Cha
- Department of Orthodontics, School of Dentistry, Dankook University, Cheonan, Korea
| | - Dong-Hwa Chung
- Department of Orthodontics, School of Dentistry, Dankook University, Cheonan, Korea
| | - Sang-Min Lee
- Department of Orthodontics, School of Dentistry, Dankook University, Cheonan, Korea
| |
Collapse
|
222
|
Shin S, Lee JW, Kim SH, Jung Y, Oh YJ. Frequency domain parameters of heart rate variability should be quoted in normalised units together with their absolute values: author's reply. Acta Anaesthesiol Scand 2014; 58:371. [PMID: 24471803 DOI: 10.1111/aas.12271] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
223
|
Ji SH, Gururani MA, Lee JW, Ahn BO, Chun SC. Isolation and characterisation of a dwarf rice mutant exhibiting defective gibberellins biosynthesis. Plant Biol (Stuttg) 2014; 16:428-39. [PMID: 23944972 DOI: 10.1111/plb.12069] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/12/2013] [Accepted: 06/06/2013] [Indexed: 05/02/2023]
Abstract
We have isolated a severe dwarf mutant derived from a Ds (Dissociation) insertion mutant rice (Oryza sativa var. japonica c.v. Dongjin). This severe dwarf phenotype, has short and dark green leaves, reduced shoot growth early in the seedling stage, and later severe dwarfism with failure to initiate flowering. When treated with bioactive GA3 , mutants are restored to the normal wild-type phenotype. Reverse transcription PCR analyses of 22 candidate genes related to the gibberellin (GA) biosynthesis pathway revealed that among 22 candidate genes tested, a dwarf mutant transcript was not expressed only in one OsKS2 gene. Genetic analysis revealed that the severe dwarf phenotype was controlled by recessive mutation of a single nuclear gene. The putative OsKS2 gene was a chromosome 4-located ent-kaurene synthase (KS), encoding the enzyme that catalyses an early step of the GA biosynthesis pathway. Sequence analysis revealed that osks2 carried a 1-bp deletion in the ORF region of OsKS2, which led to a loss-of-function mutation. The expression pattern of OsKS2 in wild-type cv Dongjin, showed that it is expressed in all organs, most prominently in the stem and floral organs. Morphological characteristics of the dwarf mutant showed dramatic modifications in internal structure and external morphology. We propose that dwarfism in this mutant is caused by a point mutation in OsKS2, which plays a significant role in growth and development of higher plants. Further investigation on OsKS2 and other OsKS-like proteins is underway and may yield better understanding of the putative role of OsKS in severe dwarf mutants.
Collapse
Affiliation(s)
- S H Ji
- Department of Molecular Biotechnology, Konkuk University, Seoul, Korea
| | | | | | | | | |
Collapse
|
224
|
Cho SG, Lee JW, Heo JS, Kim SY. Gene Expression Change in Human Dental Pulp Cells Exposed to a Low-Level Toxic Concentration of Triethylene Glycol Dimethacrylate: An RNA-seq Analysis. Basic Clin Pharmacol Toxicol 2014; 115:282-90. [DOI: 10.1111/bcpt.12197] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2013] [Accepted: 01/02/2014] [Indexed: 12/17/2022]
Affiliation(s)
- Sung-Geun Cho
- Department of Conservative Dentistry; School of Dentistry; Kyung Hee University; Seoul Korea
| | - Jin-Woo Lee
- Department of Conservative Dentistry; School of Dentistry; Kyung Hee University; Seoul Korea
| | - Jung Sun Heo
- Department of Maxillofacial Biomedical Engineering; School of Dentistry; Kyung Hee University; Seoul Korea
| | - Sun-Young Kim
- Department of Conservative Dentistry; School of Dentistry; Kyung Hee University; Seoul Korea
| |
Collapse
|
225
|
McAuley DF, Curley GF, Hamid UI, Laffey JG, Abbott J, McKenna DH, Fang X, Matthay MA, Lee JW. Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation. Am J Physiol Lung Cell Mol Physiol 2014; 306:L809-15. [PMID: 24532289 DOI: 10.1152/ajplung.00358.2013] [Citation(s) in RCA: 116] [Impact Index Per Article: 11.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023] Open
Abstract
The lack of suitable donors for all solid-organ transplant programs is exacerbated in lung transplantation by the low utilization of potential donor lungs, due primarily to donor lung injury and dysfunction, including pulmonary edema. The current studies were designed to determine if intravenous clinical-grade human mesenchymal stem (stromal) cells (hMSCs) would be effective in restoring alveolar fluid clearance (AFC) in the human ex vivo lung perfusion model, using lungs that had been deemed unsuitable for transplantation and had been subjected to prolonged ischemic time. The human lungs were perfused with 5% albumin in a balanced electrolyte solution and oxygenated with continuous positive airway pressure. Baseline AFC was measured in the control lobe and if AFC was impaired (defined as <10%/h), the lungs received either hMSC (5 × 10(6) cells) added to the perfusate or perfusion only as a control. AFC was measured in a different lung lobe at 4 h. Intravenous hMSC restored AFC in the injured lungs to a normal level. In contrast, perfusion only did not increase AFC. This positive effect on AFC was reduced by intrabronchial administration of a neutralizing antibody to keratinocyte growth factor (KGF). Thus, intravenous allogeneic hMSCs are effective in restoring the capacity of the alveolar epithelium to remove alveolar fluid at a normal rate, suggesting that this therapy may be effective in enhancing the resolution of pulmonary edema in human lungs deemed clinically unsuitable for transplantation.
Collapse
Affiliation(s)
- D F McAuley
- Health Sciences Bldg., 97, Lisburn Rd., Belfast, Northern Ireland, BT9 7BL.
| | | | | | | | | | | | | | | | | |
Collapse
|
226
|
Gennai S, Monsel A, Lee JW. [Mesenchymal stem cells: a new perspective of treatment of the acute respiratory distress syndrome]. ACTA ACUST UNITED AC 2014; 33:52-3. [PMID: 24378042 DOI: 10.1016/j.annfar.2013.11.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2013] [Accepted: 11/10/2013] [Indexed: 11/24/2022]
Affiliation(s)
- S Gennai
- Pôle urgences Samu-Smur, CHU de Grenoble, CS 10217, 38043 Grenoble cedex 09, France; Laboratoire TIMC-IMAG, UMR 5525, domaine de la Merci, 38706 La Tronche cedex, France; Cardio Vascular Research Institute, University of California, 505, Parnassus avenue, Box 0648, San Francisco, CA 94143-0648, États-Unis.
| | - A Monsel
- Cardio Vascular Research Institute, University of California, 505, Parnassus avenue, Box 0648, San Francisco, CA 94143-0648, États-Unis
| | - J W Lee
- Cardio Vascular Research Institute, University of California, 505, Parnassus avenue, Box 0648, San Francisco, CA 94143-0648, États-Unis
| |
Collapse
|
227
|
Yoo TK, Han W, Moon HG, Kim J, Lee JW, Kim MK, Lee E, Kim J, Noh DY. Abstract P6-06-08: Impact of initial surgical treatment delay on survival according to hormone responsiveness in breast cancer. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p6-06-08] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Previous studies on the issue of the prognostic importance of treatment delay in breast cancer have shown inconsistent results. Furthermore, the association between the impact of treatment delay and molecular characteristics of tumors has not been adequately addressed. The purpose of this study is to examine the prognostic impact of initial surgical treatment delay after biopsy-proven cancer diagnosis in breast cancer patients.
A total of 1,393 consecutive invasive breast cancer patients, treated in Seoul National University Hospital, Seoul, Korea, between July 2006 and June 2008, were included in this study. Patients with in situ or metastatic carcinoma at the time of diagnosis and patients in whom the dates of the initial pathologic diagnosis were unknown were excluded.
The median time from biopsy-confirmed cancer diagnosis to initial surgical treatment was 25 days (range 0-134). When the patients were classified according to their treatment delay days (0 to 29, 30 to 59, and ≥60days), there was no difference in survival between ‘0-29days’ group and ‘30-59days’ group. However, for patients who experienced more than 60 days of initial delay in surgical treatment, the survival was significantly worse when compared to other groups (p = 0.034). The association between the treatment delay and poor outcome was only seen in patients with ER and PR negative tumors (p = 0.018) while patients with hormone-responsive tumors showed no such association. Patients with ER and PR negative tumors developed more recurrence and had shorter disease-free survival if they had treatment delay of more than 60 days. The prognostic importance of treatment delay of more than 60 days remained significant in predicting disease-free survival after adjusting for other known prognostic factors such as age, tumor size, nodal status, cancer stage, nuclear grade and Ki-67 expression (HR 5.127; 95% CI, 1.350 to 19.472; p = 0.016).
Our results suggest that having treatment delay of more than 60 days is associated with poor treatment outcome in patients with ER and PR negative breast cancer.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P6-06-08.
Collapse
Affiliation(s)
- T-K Yoo
- Seoul National University College of Medicine, Seoul, Republic of Korea
| | - W Han
- Seoul National University College of Medicine, Seoul, Republic of Korea
| | - H-G Moon
- Seoul National University College of Medicine, Seoul, Republic of Korea
| | - J Kim
- Seoul National University College of Medicine, Seoul, Republic of Korea
| | - JW Lee
- Seoul National University College of Medicine, Seoul, Republic of Korea
| | - MK Kim
- Seoul National University College of Medicine, Seoul, Republic of Korea
| | - E Lee
- Seoul National University College of Medicine, Seoul, Republic of Korea
| | - J Kim
- Seoul National University College of Medicine, Seoul, Republic of Korea
| | - D-Y Noh
- Seoul National University College of Medicine, Seoul, Republic of Korea
| |
Collapse
|
228
|
Lee JW, Kim HJ, Son BH, Ahn SH. Abstract P6-06-24: Intact p53 can predict more hormonal therapy benefit in invasive breast cancer: Evaluation of interactions between immunohistochemical p53 status and adjuvant therapy. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p6-06-24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: To confirm the prognostic and predictive values of p53 accumulation, particularly in invasive breast cancer patients sorted according to subgroup based on immunohistochemical hormone receptor (HR) and HER2 status.
Methods: A total of 15,598 immunohistochemical data for p53, ER, PgR, and HER2 were retrospectively retrieved from the web-based database of the Korean Breast Cancer Society. Overall survival (OS) and breast cancer-specific survival (BCSS) were calculated and compared with the Kaplan-Meier method with log-rank test. Multivariate analyses were performed using a stratified Cox proportional hazard regression model. A model evaluating interactions between p53 and both hormonal therapy and chemotherapy was used to determine the treatment benefit from both modalities.
Results: Prognostic value of p53 was most significant in the HR+/HER2- subgroup for OS and BCSS, with hazard ratios of 1.44 (95% CI, 1.08-1.93) and of 1.47 (95% CI, 1.09-1.99). The hazard ratios for p53 overexpression had borderline significance in the HR+/HER2+, and were invalid in the HR-/HER2+ and HR-/HER2- subgroups. The model with interaction terms revealed that hormonal therapy significantly interacts with p53 status (p = .002 and .007 for OS and BCSS), resulting in an insignificant prognostic value of p53 status (p = .268 and .296 for OS and BCSS). An interaction between chemotherapy and p53 status was not found in this model.
Conclusion: p53 overexpression has independent prognostic value, particularly in the HR+/HER2- invasive breast cancer, which is most likely caused by differential treatment benefits from hormonal therapy depending on p53 status.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P6-06-24.
Collapse
Affiliation(s)
- JW Lee
- University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
| | - HJ Kim
- University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
| | - BH Son
- University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
| | - SH Ahn
- University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
| |
Collapse
|
229
|
Sohn G, Son BH, Baek S, Lee S, Lee Y, Kim HJ, Ko BS, Yu J, Lee JW, Ahn SH. Abstract P6-06-54: Analysis of treatment and survival of pathologic occult breast cancer with axillary lymph node metastasis: Nationwide retrospective study. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p6-06-54] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Objective
Occult breast cancer (OBC) is a rare presentation which accounts for 0.3-1.0% of all breast cancers. In spite of limited information, there is no consensus regarding the prognostic factors and treatment of OBC. This retrospective study intends to evaluate the overall survival and prognostic factors of occult breast cancer (OBC) in Korea.
Method
This study included 142 pathologic occult breast cancer patients from January 1990 to December 2009, identified from Korean Breast Cancer Society cancer registry. All patients had pathologically positive axillary lymph node (N1-N3) along with pathologically & radiologically negative in-breast lesion (T0/Tx) based on retrospective review of database. Among 142 patients, 32 patients had only axillary lymph node dissection (ALND), 56 patients had breast conserving operation (BCO) with ALND and 54 patients had mastectomy with ALND. 96 patients (96%) had N1 disease, 23 patients (16.2%) had N2 disease and 23 patients (16.2%) had N3 disease.
Results
There was no significant statistical difference in overall survival among different operation method, which is ALND only, BCO with ALND, mastectomy with ALND (p = 0.061), considering that 12 patients (37.5%) among 32 patients who only had ALND had N3 disease comparing that only 7 (12.5%) out of 56 patients and 4 (7.4%) out of 54 patients had N3 disease in BCO with ALND and mastectomy with ALND group separately. Univariate analysis revealed that only nodal status was significant prognostic factor (p = 0.0004), and other factors including radiotherapy (p = 0.696), chemotherapy (p = 0.302), estrogen receptor positivity (p = 0.144), progesterone receptor positivity (p = 0.254), total number of removed lymph node (p = 0.586) didn't show statistical difference in overall survival.
Conclusions
This study suggests that OBC patients who only had ALND showed similar outcomes when comparing with patients who had BCO with ALND or mastectomy with ALND. Also only nodal status might be independent predictors for poor outcomes of occult breast cancer.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P6-06-54.
Collapse
Affiliation(s)
- G Sohn
- Asan Medical Center, Seoul, Korea
| | - BH Son
- Asan Medical Center, Seoul, Korea
| | - S Baek
- Asan Medical Center, Seoul, Korea
| | - S Lee
- Asan Medical Center, Seoul, Korea
| | - Y Lee
- Asan Medical Center, Seoul, Korea
| | - HJ Kim
- Asan Medical Center, Seoul, Korea
| | - BS Ko
- Asan Medical Center, Seoul, Korea
| | - J Yu
- Asan Medical Center, Seoul, Korea
| | - JW Lee
- Asan Medical Center, Seoul, Korea
| | - S-H Ahn
- Asan Medical Center, Seoul, Korea
| |
Collapse
|
230
|
Kim MK, Moon HG, Kim J, Lee JW, Kim J, Lee ES, Yoo TK, Noh DY, Han W. Abstract P3-14-20: Neoadjuvant chemotherapy in young age breast cancer: Survival benefit over adjuvant chemotherapy in clinically T2 node positive patients. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p3-14-20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: The downstaging of the primary tumor and the increase in breast conservation rates seems to be the only clinical benefit of Neoadjuvant systemic therapy(NST) in breast cancer treatment, given that several studies failed to demonstrate an improvement of overall survival compared with postoperative adjuvant chemotherapy. In Europe, S6 trial showed better early outcome in survival in favour of the neoadjuvant chemotherapy group compared to adjuvant chemotherapy group in premenopausal patients without significantly modifying long-term event rates. The aim of this study was to assess a potential advantage in survival by neoadjuvant as compared to adjuvant chemotherapy in young age breast cancer patients.
Methods: Between January 2001 and December 2008, 1169 consecutive patients with breast cancer aged under 40 underwent adjuvant chemotherapy before or after surgery. Prospectively collected medical records for all patients were reviewed retrospectively. For the comparison of survival between neoadjuvant versus adjuvant chemotherapy group, cinically T2 and node positive patients were retrieved. Survival curves were derived from Kaplan-Meier estimates and compared by log-rank test.
Results: Of the 1169 patients, 203(17.3%) patients were treated with neoadjuvant chemotherapy, and they were grouped as ‘NST’ and ‘non-NST’ according to initial treatment. About 47% patients in each group were clinically T2 patients. (99(47.8%) in NST group, 453(46.9%) in non-NST group) Among them, clinically T2 and node positive patients were 188, 97 patients in NST group, 91 patients in non-NST group each. The median age was 35.11±3.9 years old and HER2 amplification was observed as 23.5%, and they were not different between two groups.(p = 0.146 and 0.941 each) Significant lower hormone receptor expression rate and higher Ki-67 level were observed in NST group(p = 0.03 and <0.0001 each) Breast conservation surgery rate was also significantly different between two groups, more favorable results in NST group.(67% in NST group, 37.4% in non-NST group, p<0.0001) During median follow-up period of 61 months (range 44 to 148 months), we observed a statistically significant difference (p = 0.011) in survival in favour of the NST group. This benefit of survival was presented consistently regardless of hormone receptor expression. A similar trend was seen when the time to distant disease recurrence was evaluated (p = 0.176). And this trend was more prominent in hormone receptor negative patients, but still not statistically significant. (p = 0.144) The mean total dose of chemotherapy administered was similar in both groups. Improved survival figures in the NST group could be the result of the early initiation of systemic treatment, but the trend in favour of decreased metastases was not statistically significant.
Conclusion: A potential advantage of primary over adjuvant chemotherapy in young age breast cancer patients’ survival might be proposed by this results.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P3-14-20.
Collapse
Affiliation(s)
- MK Kim
- Seoul National University Hospital, Seoul, Korea
| | - H-G Moon
- Seoul National University Hospital, Seoul, Korea
| | - J Kim
- Seoul National University Hospital, Seoul, Korea
| | - JW Lee
- Seoul National University Hospital, Seoul, Korea
| | - J Kim
- Seoul National University Hospital, Seoul, Korea
| | - ES Lee
- Seoul National University Hospital, Seoul, Korea
| | - T-K Yoo
- Seoul National University Hospital, Seoul, Korea
| | - D-Y Noh
- Seoul National University Hospital, Seoul, Korea
| | - W Han
- Seoul National University Hospital, Seoul, Korea
| |
Collapse
|
231
|
Lee JW, Moon HG, Han W, Noh DY. Abstract P3-07-09: Breast cancer susceptibility associated single nucleotide polymorphisms (SNPs) and prognosis: GG genotype of a SNP rs3803662 (TOX3/TNRC9) associated with better survival. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p3-07-09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Backgrounds: After completion of human genome project, some genetic variants are discovered and highlighted by genome-wide association studies (GWAS). Single nucleotide polymorphisms (SNP) are considered to be the key variations leading to the various breast cancer susceptibility between each individuals. In 2011, our group has validated 5 SNPs as significant risk factor of breast cancer in Korean women for the first time. Recently, there has been some attempts to find clinical meaning of SNPs in each breast cancer patient. But it was not successful.
Methods: Consecutive patients with histologically confirmed primary breast cancer subjected to operative procedures between 2002 and 2009 in Seoul National University Hospital were included for analysis. Patients diagnosed with noninvasive breast cancer (ductal carcinoma in situ and lobular carcinoma in situ) or stage IV breast cancer were excluded. Peripheral venous blood samples were obtained and stored at the time of operation. The SNPs genotyped included rs2046210 (6q25.1), rs2981582 (FGFR2), rs889312 (MAP3K1), rs3803662 (TOX3/TNRC9), and rs4973768 (SLC4A7). SNP genotyping was carried out on an Applied Biosystems 7900HT realtime PCR system (Applied Biosystems). We made collaboration with the Korean Central Cancer Registry (KCCR) to improve the validity of the mortality data. Total of 3,209 patients were included for survival and recurrence analysis.
Results: 492 (15.33%) patients had recurrence. And there were 277 (8.63%) mortalities overall. The median follow-up was for 85.59 month (±29.979). The GG genotype of SNP rs3803662 showed better survival than other AA, AG genotypes (Cumulative survival was 89% vs 84% at 120 months f/u). And it is validated at multivariate analysis (p = 0.024).
Conclusion: This study showed strong association between a certain genotype of single SNP and survival of breast cancer patients for the first time. Further lab investigation including functional study or studies on other races should be performed to find a novel or alternative hidden pathways of cancer progression.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P3-07-09.
Collapse
Affiliation(s)
- JW Lee
- Seoul National University Hospital, Seoul, Republic of Korea
| | - H-G Moon
- Seoul National University Hospital, Seoul, Republic of Korea
| | - W Han
- Seoul National University Hospital, Seoul, Republic of Korea
| | - D-Y Noh
- Seoul National University Hospital, Seoul, Republic of Korea
| |
Collapse
|
232
|
Kim J, Lee HS, In YH, Moon HG, Lee M, Lee JW, Kim MK, Kim J, You T, Lee E, Park J, Noh DY, Kim S, Han W. Abstract P4-04-09: Extensive novel hybrid isoforms revealed by RNA sequencing of 120 primary breast cancer samples. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p4-04-09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction
Recent studies of next generation sequencing (NGS) have highlighted the extensive transcriptional heterogeneity of cancer cells. Alternative splicing is one of the evolutionary process by which cells and tissues achieve their specificity within central dogma. Also it is highly assumed to contribute to oncogenesis and thought to be a critical mechanism how cancer cells gain resistance to therapeutic agents and adapt to various circumstances. Relevance of differential splicing in breast cancer biology is mostly unknown. We performed whole transcriptome sequencing (RNA-Seq) to reveal novel splicing alterations among 120 primary breast cancer samples.
Materials and Method
Total RNA was prepared using the Illumina TrueSeq™ RNA sample Preparation Kit and TrueSeq mRNA library was constructed. Clustering and sequencing was done using Illumina HiSeq 2000. RNA-Seq reads were aligned to human reference genome(hg19) using TopHat software and expression was measured using cufflinks software. We used tissues extracted from previously collected 120 fresh-frozen primary breast cancer samples obtained after surgical resection whose clinicopathological data are available. Patients undergone neoadjuvant systemic therapies or stage lV disease at diagnosis were excluded. Thirty-six(30%) cases occurred distant metastasis during follow up. Hormone receptor(HR) was positive in 61(50.8%) samples, 20(16.7%) had HER2 oncogene overexpression and 36(30%) were triple negative breast cancer.
Results and discussion
Total 11345 novel isoforms were detected among 120 tumors. Isoforms of pseudo-genes and exon skipping of the ‘non-coding exon’ were excluded. Splice variants detected in normal reference were sorted out as well. 4045 were in-frame exon skipping and 4960 were off-frame exon skipping which may lead to protein truncation. 5036 were private exon skipping and 3969 isoforms were detected recurrently in more than 2 samples. To minimize false positivity we confined ‘exon skipping’ analysis to those with the expression level (Fragments per kilo-base of exon per million fragments mapped, FPKM) of the skipped exon below 0.1 compared to the adjacent exons. Mean number of exon skipping events per sample was 196.8 (range 75-299, SD 35.9). There were no differences in numbers of exon skipping event among breast cancer subtypes nor distant metastasis. We have identified novel exon skipping in ESR1, CHEK2, EIF3E, FGFR, MAP2K, PIK3R2, TERT, VAV3 genes which is strongly suspected to be novel driver isoforms and is under validation process.
Conclusion We performed whole-transcriptome sequencing with a large set of primary breast cancer samples and revealed extensive transcriptional heterogeneity by isoform profiling. As distinguishing the natural transcriptomic dynamics from oncogenic ‘driver’ isoform is a major challenge, validation and functional studies are ongoing.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P4-04-09.
Collapse
Affiliation(s)
- J Kim
- Seoul National University Hospital, Seoul, Korea; Macrogen Inc, Korea; Bioconvergence Research Center, Korea; Geference Inc, Korea
| | - H-S Lee
- Seoul National University Hospital, Seoul, Korea; Macrogen Inc, Korea; Bioconvergence Research Center, Korea; Geference Inc, Korea
| | - Y-H In
- Seoul National University Hospital, Seoul, Korea; Macrogen Inc, Korea; Bioconvergence Research Center, Korea; Geference Inc, Korea
| | - H-G Moon
- Seoul National University Hospital, Seoul, Korea; Macrogen Inc, Korea; Bioconvergence Research Center, Korea; Geference Inc, Korea
| | - M Lee
- Seoul National University Hospital, Seoul, Korea; Macrogen Inc, Korea; Bioconvergence Research Center, Korea; Geference Inc, Korea
| | - JW Lee
- Seoul National University Hospital, Seoul, Korea; Macrogen Inc, Korea; Bioconvergence Research Center, Korea; Geference Inc, Korea
| | - MK Kim
- Seoul National University Hospital, Seoul, Korea; Macrogen Inc, Korea; Bioconvergence Research Center, Korea; Geference Inc, Korea
| | - J Kim
- Seoul National University Hospital, Seoul, Korea; Macrogen Inc, Korea; Bioconvergence Research Center, Korea; Geference Inc, Korea
| | - T You
- Seoul National University Hospital, Seoul, Korea; Macrogen Inc, Korea; Bioconvergence Research Center, Korea; Geference Inc, Korea
| | - E Lee
- Seoul National University Hospital, Seoul, Korea; Macrogen Inc, Korea; Bioconvergence Research Center, Korea; Geference Inc, Korea
| | - J Park
- Seoul National University Hospital, Seoul, Korea; Macrogen Inc, Korea; Bioconvergence Research Center, Korea; Geference Inc, Korea
| | - D-Y Noh
- Seoul National University Hospital, Seoul, Korea; Macrogen Inc, Korea; Bioconvergence Research Center, Korea; Geference Inc, Korea
| | - S Kim
- Seoul National University Hospital, Seoul, Korea; Macrogen Inc, Korea; Bioconvergence Research Center, Korea; Geference Inc, Korea
| | - W Han
- Seoul National University Hospital, Seoul, Korea; Macrogen Inc, Korea; Bioconvergence Research Center, Korea; Geference Inc, Korea
| |
Collapse
|
233
|
Kim MK, Moon HG, Kim J, Lee JW, Yoo TK, Kim J, Lee ES, Noh DY, Han W. Abstract PD4-2: Whole exome and transcriptome sequencing of 120 primary breast cancer to discover novel therapeutic target. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-pd4-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction: Many somatic mutations, structural alterations, and gene expression changes are causally implicated in oncogenesis and tumor progression, and as a result, affect clinical outcome. Although majority of breast cancer patients have benefits from therapeutics targeting tumor biology, such as estrogen receptor and HER-2, still many patients suffer from disease recurrence and metastasis. More kind of specific target therapies are needed, especially for hormone-resistant tumor and triple-negative breast cancer.
Materials and Method: To find novel therapeutic target in breast cancer, here we examine the both whole exome and whole transcriptome of fresh-frozen primary breast cancer tissues from 120 patients whose clinical, pathological, and survival data are available. Patients with Stage IV disease or who received neoadjuvant chemotherapy were excluded. 36 patients had distant metastasis within 5 years from surgery, and 84 patients were NED at least 5 years. RNA and DNA were extracted and qualities were assessed in all samples. Exome and transcriptome sequencing were done using NGS technology (Illumina HiSeq 2000). As a control, exome sequencing was done for 93 normal DNA from matched patients. Single nucleotide variations (SNV) identified in cancer samples on exonic region, nonsynonymous SNV or stop gain/loss, whose quality ≥20, and not found in 93 normal samples were included. SNVs registered in dbSNP135_common or 1000 genome allele frequency >0.001 were excluded.Results and Discussion: We identified 11,684 putative somatic mutations in 7,373 genes. Of them, 6,547 were deleterious or damaging mutation by Provean or SIFT analysis. Mutations were found in potential drug target genes, such as PIK3CA(25), PTEN(3), AKT1(3), ALK(3), ROS1(2), FGFR4(3), FGFR3(2), ERBB2(2), and IDH1(1) etc. In a pathway analysis, mutations in insulin signaling pathway were most dominant. We hypothesized that driver gene and therapeutic target has to have recurrent mutation and gene expression at least more than average expression. We calculated expression “Volume” according to the median normalized FPKM value of individual gene's RNA-seq data. With a cut-off of 3 or more mutations in each gene, 1,116 genes were selected. After the filtering of Volume<0.3, 696 genes were selected. Finally, 55 genes were selected which are druggable or potentially druggable using drug database (DrugBank, TOCRIS, Ingenuity) and Pubmed. DriverNet analysis result was also considered for the selection. All 342 tumor suppressor genes were filtered out. Interestingly, 18 of the 55 were genes involved in metabolism (fatty acid, glucose, amino acids). 12 were kinases and 4 were involved in insulin pathway. Excluding the previously confirmed therapeutic target, PIK3CA, AKT1, and NOTCHs, and considering the patients’ clinical data, our primary candidates for hormone-resistant breast cancer were NQO2, CELSR1, GLUD2, MYH9, PSMD2, NADK, IRS2, MAP3K5, and for triple-negative breast cancer were HSPG2, PHGDH, MYLK, etc. Validation with Sanger sequencing and functional study is on-going.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr PD4-2.
Collapse
Affiliation(s)
- MK Kim
- Seoul National University Hospital, Seoul, Korea
| | - H-G Moon
- Seoul National University Hospital, Seoul, Korea
| | - J Kim
- Seoul National University Hospital, Seoul, Korea
| | - JW Lee
- Seoul National University Hospital, Seoul, Korea
| | - T-K Yoo
- Seoul National University Hospital, Seoul, Korea
| | - J Kim
- Seoul National University Hospital, Seoul, Korea
| | - ES Lee
- Seoul National University Hospital, Seoul, Korea
| | - D-Y Noh
- Seoul National University Hospital, Seoul, Korea
| | - W Han
- Seoul National University Hospital, Seoul, Korea
| |
Collapse
|
234
|
Lee E, Han W, Moon HG, Kim J, Lee JW, Kim MK, Yoo TK, Kim J, Noh DY. Abstract P5-15-04: Clinical benefits of using nomogram for predicting positive resection margins in breast conserving surgery. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p5-15-04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Achieving a clear resection margin in breast conserving surgery (BCS) is an important factor in tumor recurrence in breast cancer. To obtain clear resection margins and reduce re-excision rates, some surgeons obtain intraoperative assessments of the margins of excised specimens, using intraoperative frozen biopsy. But intraoperative frozen biopsy has several problems such as low sensitivity or longer operation time. We have previously reported a nomogram for prediction of positive resection margin by integrating preoperatively available clinical and pathologic information. The factors were the presence of microcalcification, mammographic density, tumor size discrepancy between magnetic resonance imaging and ultrasonography, and the presence of ductal carcinoma in situ or lobular carcinoma in needle biopsy specimens.
We conducted a prospective trial to examine the accuracy and clinical benefits of the nomogram in 442 breast cancer patients (nomogram group) who underwent BCS between Dec 2011 and March 2013, and compared the clinical outcome with that of the 253 patients (control group) who underwent BCS between Jan 2011 and Oct 2011. For nomogram group, the intraoperative frozen section biopsy was omitted in patients with low nomogram scores.
Applying our nomogram did not increase the rate of reoperation due to resection margin positivity when compared to the control group (6.56% vs. 4.25%, respectively, p = 0.22). In the nomogram group, the reoperation rate in patients with low nomogram score who did not undergo intraoperative frozen biopsy was 3.2%, and this is lower than the reoperation rate in the control group. Additionally, we experienced a significant reduction in operation time by 15 minutes when compared to the control group (p<0.001).
In conclusion, our results show that out nomogram for predicting positive resection margin for patients who receive BCS can significantly reduce the operation time without increasing reoperation rate.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P5-15-04.
Collapse
Affiliation(s)
- E Lee
- Seoul National University College of Medicine, Seoul, Republic of Korea
| | - W Han
- Seoul National University College of Medicine, Seoul, Republic of Korea
| | - H-G Moon
- Seoul National University College of Medicine, Seoul, Republic of Korea
| | - J Kim
- Seoul National University College of Medicine, Seoul, Republic of Korea
| | - JW Lee
- Seoul National University College of Medicine, Seoul, Republic of Korea
| | - MK Kim
- Seoul National University College of Medicine, Seoul, Republic of Korea
| | - T-K Yoo
- Seoul National University College of Medicine, Seoul, Republic of Korea
| | - J Kim
- Seoul National University College of Medicine, Seoul, Republic of Korea
| | - D-Y Noh
- Seoul National University College of Medicine, Seoul, Republic of Korea
| |
Collapse
|
235
|
An HS, Lee JW, Park JY, Myeong JI, An CM. Mitochondrial and microsatellite DNA analyses showed comparative genetic diversity between parent and offspring populations of Korean black rockfish in a hatchery facility. Genet Mol Res 2013; 12:6389-401. [PMID: 24390988 DOI: 10.4238/2013.december.9.2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
The black rockfish, Sebastes inermis (Sebastidae), is an important commercial fishery resource in Korea. As a preliminary investigation into the effect of artificial reproduction in a hatchery facility, the genetic divergence between parent and offspring populations of black rockfish was accessed using 10 polymorphic nuclear microsatellite DNA loci and a mitochondrial (mt) control gene. All loci that were screened showed marked polymorphisms. mtDNA control region sequences were also highly variable. Of approximately 350 base pairs (bp) sequenced, 52 variable sites, comprising 56 base substitutions, were found among 233 individuals. Offspring populations showed less genetic variability than the parent population in terms of numbers of microsatellite alleles and mtDNA haplotypes, as well as mtDNA haplotype diversity. Statistical analysis of the fixation index (ΦST and F(ST)) and analysis of molecular variance using both DNA markers showed significant genetic differences between the parent and offspring populations. These results suggest that random genetic drift and/or inbreeding events, as well as artificial selection and founder effects, occurred when the offspring strain was reproduced in a hatchery facility despite thousands of males and females from different hatcheries being maintained for artificial reproduction. Therefore, it is necessary to improve current hatchery programs by monitoring genetic variation in both the broodstock and progeny and controlling inbreeding within stocks in commercial breeding facilities to maintain the production of high-quality black rockfish. This information will be useful for determining suitable guidelines for establishing and maintaining cultured stocks and the aquaculture industry of S. inermis.
Collapse
Affiliation(s)
- H S An
- Biotechnology Research Division, National Fisheries Research and Development Institute, Busan, Korea
| | | | | | | | | |
Collapse
|
236
|
An HS, Shin EH, Lee JW, Nam MM, Myeong JI, An CM. Comparative genetic variability between broodstock and offspring populations of Korean starry flounder used for stock enhancement in a hatchery by using microsatellite DNA analyses. Genet Mol Res 2013; 12:6319-30. [PMID: 24338427 DOI: 10.4238/2013.december.4.19] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Korean starry flounder, Platichthys stellatus (Pleuronectidae), is one of the most economically important fishery resources in Korea. We investigated the effect of current artificial reproduction in a hatchery facility, genetic divergence between the broodstock and their offspring populations of starry flounder in a hatchery strain to be stocked into natural sea areas was accessed using 9 polymorphic nuclear microsatellite DNA loci. High levels of polymorphism were observed between the 2 populations. A total of 96 alleles were detected at the loci, with some alleles being unique in the broodstock. Allelic variability ranged from 8 to 17 in the broodstock and from 7 to 12 in the offspring population. Average observed and expected heterozygosities were estimated at 0.565 and 0.741 in the broodstock samples and 0.629 and 0.698 in the offspring population, respectively. Although no statistically significant reductions were found in heterozygosity or allelic diversity in the offspring population, a considerable loss of rare alleles was observed in the offspring population compared with that in the broodstock. Significant genetic difference was detected between the broodstock and offspring populations (FST = 0.021, P < 0.05). These results suggest that more intensive breeding practices for stock enhancement might have resulted in a further decrease of genetic diversity. Thus, genetic variations of broodstock and progeny should ideally be monitored in both breeding and release programs as a routine hatchery operation in order to improve the starry flounder hatchery management. This information might be useful for fishery management and aquaculture industry of P. stellatus.
Collapse
Affiliation(s)
- H S An
- Biotechnology Research Division, National Fisheries Research and Development Institute, Busan, Korea
| | | | | | | | | | | |
Collapse
|
237
|
Lee SK, Lee JW, Choy WS. Is multimodal analgesia as effective as postoperative patient-controlled analgesia following upper extremity surgery? Orthop Traumatol Surg Res 2013; 99:895-901. [PMID: 24183743 DOI: 10.1016/j.otsr.2013.09.005] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/09/2013] [Revised: 06/13/2013] [Accepted: 09/06/2013] [Indexed: 02/02/2023]
Abstract
INTRODUCTION The present prospective study compared the clinical outcomes between a multimodal analgesia group and a patient-controlled analgesia (PCA) group for postoperative pain control in upper extremities surgery. HYPOTHESIS Multimodal analgesia including pre-emptive analgesic can provide similar or superior analgesic effects and a lower incidence of adverse reactions than PCA following upper extremity surgery. PATIENTS AND METHODS Sixty-one patients undergoing upper extremity surgery were randomized to 2 perioperative analgesic groups (multimodal analgesia and PCA). We compared the clinical outcomes: use of additional pain rescue, opioid-related complication rate, and patient's satisfaction between the 2 groups. RESULTS No significant differences on the resting and exercise pain scores between the two groups. Also, there were no differences regarding additional pain rescue during postoperative day (POD) 1, 2 and achievement of rehabilitation protocol in both groups. However, use of additional pain rescue in PCA group was increased significantly after PCA removal. Moreover, there was significant difference in the incidence of opioid-related complications on operation day and at POD 1. At discharge, multimodal analgesia group showed significantly greater satisfaction than PCA group. DISCUSSION Perioperative pain management following upper extremity surgery through the multimodal analgesia could be an acceptable alternative method that can provide good results.
Collapse
Affiliation(s)
- S K Lee
- Department of Orthopedic Surgery, Eulji University College of Medicine, 1306 Dunsan-dong, Seo-gu, Daejeon 302-799, Republic of Korea.
| | | | | |
Collapse
|
238
|
Guillo S, Bauer T, Lee JW, Takao M, Kong SW, Stone JW, Mangone PG, Molloy A, Perera A, Pearce CJ, Michels F, Tourné Y, Ghorbani A, Calder J. Consensus in chronic ankle instability: aetiology, assessment, surgical indications and place for arthroscopy. Orthop Traumatol Surg Res 2013; 99:S411-9. [PMID: 24268842 DOI: 10.1016/j.otsr.2013.10.009] [Citation(s) in RCA: 174] [Impact Index Per Article: 15.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/20/2013] [Accepted: 10/09/2013] [Indexed: 02/02/2023]
Abstract
Ankle sprains are the most common injuries sustained during sports activities. Most ankle sprains recover fully with non-operative treatment but 20-30% develop chronic ankle instability. Predicting which patients who sustain an ankle sprain will develop instability is difficult. This paper summarises a consensus on identifying which patients may require surgery, the optimal surgical intervention along with treatment of concomitant pathology given the evidence available today. It also discusses the role of arthroscopic treatment and the anatomical basis for individual procedures.
Collapse
Affiliation(s)
- S Guillo
- Clinique du Sport, 33300 Mérignac, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
239
|
Salako O, Lo C, Couzis A, Somasundaran P, Lee JW. Adsorption of Gemini surfactants onto clathrate hydrates. J Colloid Interface Sci 2013; 412:1-6. [DOI: 10.1016/j.jcis.2013.09.007] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2013] [Revised: 08/30/2013] [Accepted: 09/03/2013] [Indexed: 10/26/2022]
Affiliation(s)
- O Salako
- Department of Chemical Engineering, The City College of New York, New York, NY 10031, USA
| | | | | | | | | |
Collapse
|
240
|
Jang JH, Lee JW, Cho EH, Lee EH, Kim JW, Ki CS. Frequency of DMPK mutation carriers in Korean women of childbearing age. Clin Genet 2013; 86:398-9. [PMID: 24274137 DOI: 10.1111/cge.12310] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2013] [Revised: 10/23/2013] [Accepted: 10/29/2013] [Indexed: 11/28/2022]
Affiliation(s)
- J-H Jang
- Green Cross Laboratories, Yongin-si, Gyeonggi-do, South Korea; Green Cross Genome, Yongin-si, Gyeonggi-do, South Korea
| | | | | | | | | | | |
Collapse
|
241
|
Brahmer JR, Lee JW, Traynor AM, Hidalgo MM, Kolesar JM, Siegfried JM, Guaglianone PP, Patel JD, Keppen MD, Schiller JH. Dosing to rash: a phase II trial of the first-line erlotinib for patients with advanced non-small-cell lung cancer an Eastern Cooperative Oncology Group Study (E3503). Eur J Cancer 2013; 50:302-8. [PMID: 24246704 DOI: 10.1016/j.ejca.2013.10.006] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2013] [Revised: 09/30/2013] [Accepted: 10/07/2013] [Indexed: 11/19/2022]
Abstract
BACKGROUND The development of a rash has been retrospectively associated with increased response and improved survival when treated with erlotinib at the standard dose of 150 mg per day. The objective of this trial was to evaluate the association of the activity of erlotinib in the first-line setting in patients with advanced non-small-cell lung cancer (NSCLC) with the development of a tolerable rash via dose escalation of erlotinib or tumour characteristics. METHODS Patients, with advanced NSCLC without prior systemic therapy, were treated with erlotinib 150 mg orally per day. The dose was increased by 25mg every two weeks until the development of grade 2/tolerable rash or other dose limiting toxicity. Tumour biopsy specimens were required for inclusion. RESULTS The study enrolled 137 patients, 135 were evaluable for safety and 124 were eligible and evaluable for response. Only 73 tumour samples were available for analysis. Erlotinib dose escalation occurred in 69/124 patients. Erlotinib was well tolerated with 70% of patients developing a grade 1/2 rash and 10% developing grade 3 rash. Response rate and disease control rate were 6.5% and 41.1% respectively. Median overall survival was 7.7 months. Toxicity and tumour markers were not associated with response. Grade 2 or greater skin rash and low phosphorylated mitogen-activated protein kinase (pMAPK) were associated with improved survival. CONCLUSIONS Overall survival was similar in this trial compared to first-line chemotherapy in this unselected patient population. Dose escalation to the development of grade 2 skin rash was associated with improved survival in this patient population.
Collapse
Affiliation(s)
- J R Brahmer
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, United States.
| | - J W Lee
- Dana-Farber Cancer Institute, Boston, MA, United States
| | - A M Traynor
- University of Wisconsin, Madison, WI, United States
| | | | - J M Kolesar
- University of Wisconsin, Madison, WI, United States
| | - J M Siegfried
- University of Pittsburgh, Pittsburgh, PA, United States
| | | | - J D Patel
- Northwestern University, Chicago, IL, United States
| | - M D Keppen
- Sanford Cancer Center, Sioux Falls, SD, United States
| | - J H Schiller
- University of Texas Southwestern Medical Center, Dallas, TX, United States
| |
Collapse
|
242
|
Park JS, Jeong S, Lee DH, Bang BW, Lee JI, Lee JW, Kwon KS, Kim HK, Shin YW, Kim YS, Park SG. Risk factors for long-term outcomes after initial treatment in hepatolithiasis. J Korean Med Sci 2013; 28:1627-31. [PMID: 24265526 PMCID: PMC3835505 DOI: 10.3346/jkms.2013.28.11.1627] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/06/2013] [Accepted: 08/29/2013] [Indexed: 12/12/2022] Open
Abstract
Hepatobiliary complications, such as stone recurrence, recurrent cholangitis, liver abscess, secondary biliary cirrhosis, and cholangiocarcinoma may occur after treatment for hepatolithiasis. However, few previous studies have addressed the risk factors and long-term outcomes after initial treatment. Eighty-five patients with newly diagnosed hepatolithiasis, actively treated for hepatolithiasis, constituted the cohort of this retrospective study. Patients were treated by hepatectomy or nonoperative percutaneous transhepatic cholangioscopic lithotomy. Long-term complications, such as recurrent cholangitis, liver abscess, secondary biliary cirrhosis, and cholangiocarcinoma, and their relationships with clinical parameters were analyzed. The mean follow-up period was 57.4 months. The overall hepatobiliary complication rate after the treatment was 17.6%. Multivariate analysis of suspected risk factors showed that complications were associated with age (HR, 1.046; CI, 1.006-1.089), bile duct stricture (HR, 4.894; CI, 1.295-18.495), and residual stones (HR, 3.482; CI, 1.214-9.981). In conclusion, several long-term hepatobiliary complications occur after hepatolithiasis treatment, and regular observation is necessary in patients with concomitant biliary stricture or residual stones.
Collapse
Affiliation(s)
- Jin-Seok Park
- Digestive Disease Center, Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea
| | - Seok Jeong
- Digestive Disease Center, Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea
- The National Center of Efficacy Evaluation for the Development of Health Products Targeting Digestive Disorders (NCEED), Incheon, Korea
| | - Don Haeng Lee
- Digestive Disease Center, Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea
- The National Center of Efficacy Evaluation for the Development of Health Products Targeting Digestive Disorders (NCEED), Incheon, Korea
- Utah-Inha DDS & Advanced Therapeutics Research Center, Incheon, Korea
| | - Byoung Wook Bang
- Digestive Disease Center, Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea
| | - Jung Il Lee
- Digestive Disease Center, Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea
| | - Jin-Woo Lee
- Digestive Disease Center, Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea
| | - Kye Sook Kwon
- Digestive Disease Center, Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea
| | - Hyung Kil Kim
- Digestive Disease Center, Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea
| | - Yong Woon Shin
- Digestive Disease Center, Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea
| | - Young Soo Kim
- Digestive Disease Center, Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea
| | - Shin Goo Park
- Department of Occupational and Environmental Medicine, Inha University School of Medicine, Incheon, Korea
| |
Collapse
|
243
|
Abstract
PURPOSE To investigate the intraocular pressure (IOP) and retinal nerve fibre layer (RNFL) thickness after ipsilateral neck dissection with internal jugular vein (IJV) removal for head and neck tumours. METHODS A computer search was performed to identify all patients who were treated with neck dissection with unilateral IJV removal from 2005 to 2012. All patients underwent a complete ophthalmological examination including measurement of IOP by Goldmann applanation tonometry and the average RNFL thickness using a Spectralis optical coherence tomography. The following analyses were made between the eyes on the side of the IJV removal versus the eye on the contralateral side: gonioscopy, IOP, vertical cup-disc ratio (VCDR) and peripapillary RNFL. Correlation analysis between the year of operation and IOP was done using the Pearson correlation coefficient. RESULTS This prospective cross-sectional study recruited 38 patients. The median age at operation was 59.5 years (range 33-87 years). There were 26 males and 12 females. Exactly half of the patients had left IJV removal and the remaining half had right IJV removal. The median interval from neck dissection to eye assessment was 46.5 months (range 11-97 months). There was no significant difference between the ipsilateral and contralateral side in terms of gonioscopy, IOP, VCDR, and RNFL. There was no significant correlation between the duration of IJV removal and IOP (p=0.8). CONCLUSIONS Ipsilateral IJV removal after neck dissection did not result in any significant differences in the average peripapillary RNFL thickness or IOP compared to the contralateral eye at a mean of 46.5 months postoperatively.
Collapse
Affiliation(s)
- R C Chan
- Division of Head and Neck Surgery, Department of Surgery, Queen Mary Hospital, , Pokfulam, Hong Kong
| | | | | | | |
Collapse
|
244
|
Kwon HJ, Kang JH, Lee JW, Chung NG, Kim HK, Cho B. Treatment of BK virus-associated hemorrhagic cystitis in pediatric hematopoietic stem cell transplant recipients with cidofovir: a single-center experience. Transpl Infect Dis 2013; 15:569-74. [PMID: 24028353 DOI: 10.1111/tid.12136] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2012] [Revised: 01/08/2013] [Accepted: 03/24/2013] [Indexed: 01/07/2023]
Abstract
BACKGROUND BK virus (BKV)-associated hemorrhagic cystitis (BKV-HC) is a severe complication after hematopoietic stem cell transplantation (HSCT). Cidofovir (CDV) has emerged as an effective agent for the treatment of BKV nephropathy, but its use for BKV-HC in pediatric HSCT recipients has not yet been established as a standard therapy. PATIENT AND METHODS We retrospectively investigated the efficacy and safety of CDV therapy for patients with BKV-HC at a single institution and analyzed the clinical management outcomes. RESULTS From April 2009 to July 2011, 12 patients developed BKV-HC at a median of 37 days after transplant (range 15-59 days). The cumulative incidence was 9% and the median peak of the urine BKV load was 2.5 × 10(10) copies/mL (range 1.4 × 10(9) -1.2 × 10(11) copies/mL). Eleven patients received intravenous CDV (5 mg/kg/dose, with probenecid), whereas 1 patient received CDV (5 mg/kg/dose, without probenecid) intravesically. The median duration of therapy was 25 days (range 9-73 days), and a median of 2 doses was given (range 1-4). A reduction of ≥ 1 log in the BKV load was found in 11 patients, while 1 patient did not have any significant change in BKV load. Clinical improvement was observed in all cases, and no HC-related death was observed. CDV-related toxicity occurred in 1 patient (8%) and spontaneously resolved. CONCLUSIONS CDV appears to be an effective and safe treatment for BKV-HC in pediatric HSCT recipients, but prospective trials are warranted to support its use.
Collapse
Affiliation(s)
- H J Kwon
- Division of Infectious Diseases, Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea; Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA
| | | | | | | | | | | |
Collapse
|
245
|
Yang JH, KIM JB, Jung SH, Choo SJ, Lee JW, Chung CH. Short term and intermediate results of hybrid procedure in high risk patients needing aortic arch repair. J Cardiothorac Surg 2013. [PMCID: PMC3844641 DOI: 10.1186/1749-8090-8-s1-o45] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Affiliation(s)
- JH Yang
- Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - JB KIM
- Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - SH Jung
- Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - SJ Choo
- Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - JW Lee
- Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| | - CH Chung
- Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| |
Collapse
|
246
|
Chung JH, Lee JY, Kang DH, Jo JK, Lee JW, Lee SH, Lee KS, Kim TH, Han JH, Lee SW. Evaluation of patient outcome after discontinuation of alfuzosin treatment for benign prostatic hyperplasia: a multicentre, prospective study. Int J Clin Pract 2013; 67:870-5. [PMID: 23952466 DOI: 10.1111/ijcp.12108] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/18/2012] [Accepted: 12/11/2012] [Indexed: 11/27/2022] Open
Abstract
AIMS The aim of this study was to assess patient outcome after discontinuation of alfuzosin treatment in patients with benign prostatic hyperplasia (BPH). METHODS This study included 200 BPH patients. Alpha-blockers were discontinued after 12 weeks of treatment when the International Prostatic Symptom Score (IPSS) was reduced to < 8 points, peak urine flow rate (Q(max)) was increased to ≥ 15 ml/s, the postvoiding residual (PVR) urine volume was ≤ 100 ml and the patient agreed to discontinue treatment. Urinary symptoms of the patients were assessed at 4, 8, 12 and 24 weeks after discontinuation of medication, and surveys were performed asking whether patients wanted to restart administration of medication. RESULTS Of 200 enrolled patients, 142 (71.00%) received 12 weeks of treatment with 10 mg of alfuzosin. The medication was discontinued in 58 of 142 patients (40.85%) because urinary symptoms had improved. Among these patients, follow-up observations were performed for 49 patients up to 24 weeks after treatment discontinued. Of these 49 patients, 28 (57.14%) showed correct urination without a need to restart treatment up to 24 weeks after the medication was discontinued. The discontinuation group demonstrated improved voiding symptoms, including Q(max) and PVR, relative to the re-administration group at baseline. Furthermore, the discontinuation group showed a smaller prostate volume than the re-administration group (p = 0.045). CONCLUSION When patients with BPH displayed symptomatic improvement upon treatment with alpha-blockers, the improvements were maintained in a select subpopulation of patients without the need to re-administer the alpha-blockers.
Collapse
Affiliation(s)
- J H Chung
- Department of Urology, Hanyang University College of Medicine, Seoul, Korea
| | | | | | | | | | | | | | | | | | | |
Collapse
|
247
|
Kim SC, Lee JW, Yang SRE. Optical properties of Dirac electrons in a parabolic well. J Nanosci Nanotechnol 2013; 13:6345-6348. [PMID: 24205658 DOI: 10.1166/jnn.2013.7709] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
A single electron transitor may be fabricated using qunatum dots. A good model for the confinement potential of a quantum dot is a parabolic well. Here we consider such a parabolic dot made of graphene. Recently, we found counter intuitively that resonant quasi-boundstates of both positive and negative energies exist in the energy spectrum. The presence of resonant quasi-boundstates of negative energies is a unique property of massless Dirac fermions. As magnetic field B gets smaller the energy width of these states become broader and for sufficiently weak value of B resonant quasi-bound states disappear into a quasi-continuum. In the limit of small B resonant and nonresonant states transform into discrete anomalous states with a narrow probability density peak inside the well and another broad peak under the potential barrier. In this paper we compute the optical strength between resonant quasi-bound states as a function of B, and investigate how the signature of resonant quasi-bound states of Dirac electrons may appear in optical measurements.
Collapse
Affiliation(s)
- S C Kim
- Physics Department, College of Science, Korea University, Seoul 136-713, Korea
| | | | | |
Collapse
|
248
|
|
249
|
Lee JW. Early infantile onset of atypical hemolytic-uremic syndrome is caused by recessive mutations in DGKE. Clin Genet 2013; 84:342-3. [DOI: 10.1111/cge.12240] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2013] [Accepted: 07/18/2013] [Indexed: 11/27/2022]
Affiliation(s)
- JW Lee
- Department of Medical Genetics, Center for Molecular Medicine and Therapeutics, The Canadian Pharmacogenomic Network for Drug Safety (CPNDS); University of British Columbia; 950 West 28th Avenue Vancouver British Columbia V5Z4H4 Canada
| |
Collapse
|
250
|
Lee JW. Mutations in PDGFRB and NOTCH3 are the first genetic causes identified for autosomal dominant infantile myofibromatosis. Clin Genet 2013; 84:340-1. [PMID: 23865785 DOI: 10.1111/cge.12238] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2013] [Accepted: 07/15/2013] [Indexed: 11/26/2022]
Affiliation(s)
- J W Lee
- Department of Medical Genetics, The Canadian Pharmacogenomic Network for Drug Safety (CPNDS), Center for Molecular Medicine and Therapeutics, University of British Columbia, 950 West 28th Avenue, Vancouver, British Columbia, V5Z4H4, Canada.
| |
Collapse
|